|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06185 CANSINOBIO
Nominal 
30.350 -0.100 (-0.328%) | 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Turnover | 285,420 | 1253.600% | 345,182 | 1,031,041 | 4,299,702 | 18,544 |
| Cost of Sales | (98,269) | -87.679% | (1,221,201) | (1,217,648) | (1,297,769) | (13,804) |
| Gross Profit | 187,151 | -- | (876,019) | (186,607) | 3,001,933 | 4,740 |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (14,061) | -30.594% | (15,046) | (8,777) | (1,824) | (391) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (16,199) | -- | 1,217 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (229,196) | -82.141% | (1,978,884) | (1,184,001) | 1,936,787 | (396,638) | |
| Taxation | (964) | -- | 11,451 | 219,244 | (29,701) | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 4,787 | -98.914% | 484,701 | 55,326 | 7,304 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (225,373) | -73.215% | (1,482,732) | (909,431) | 1,914,390 | (396,638) | |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (21,270) | -64.008% | (56,298) | (184,741) | (25,175) | (4,221) |
| Depreciation & Amortisation | 114,496 | -15.965% | 271,476 | 229,962 | 99,417 | 31,741 |
| Directors' Emoluments | -- | -- | 21,816 | 26,049 | 22,831 | 27,008 |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | -91.000 | -73.314% | -601.000 | -368.000 | 774.000 | -172.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 80.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | 10.336% | -- |
| Cash flow per share ($) | -- | -- | (3.713) | (7.641) | 8.141 | (2.033) |
| NBV per share ($) | 20.447 | -- | 21.316 | 27.271 | 32.310 | 24.534 |
| Remarks: | Real time quote last updated: 20/12/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -225,373,000 |
| %Change | -73.215% |
| EPS / (LPS) | RMB -0.910 |
| NBV Per Share (¥) | RMB 20.447 |